These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107. Antioxidants and vitamins to reduce cardiovascular disease. Devaraj S; Jialal I Curr Atheroscler Rep; 2000 Jul; 2(4):342-51. PubMed ID: 11122764 [TBL] [Abstract][Full Text] [Related]
108. Vitamins E and C are safe across a broad range of intakes. Hathcock JN; Azzi A; Blumberg J; Bray T; Dickinson A; Frei B; Jialal I; Johnston CS; Kelly FJ; Kraemer K; Packer L; Parthasarathy S; Sies H; Traber MG Am J Clin Nutr; 2005 Apr; 81(4):736-45. PubMed ID: 15817846 [TBL] [Abstract][Full Text] [Related]
109. Antioxidants and cardiovascular disease: why do we still not have the answers? Chalmers TC Ann Intern Med; 1995 Dec; 123(11):887. PubMed ID: 7486475 [No Abstract] [Full Text] [Related]
110. Vitamin E in oxidant stress-related cardiovascular pathologies: focus on experimental studies. Turan B; Vassort G Curr Pharm Des; 2011; 17(21):2155-69. PubMed ID: 21774778 [TBL] [Abstract][Full Text] [Related]
111. Vitamin E in cardiovascular disease: has the die been cast? Yusoff K Asia Pac J Clin Nutr; 2002; 11 Suppl 7():S443-7. PubMed ID: 12492632 [TBL] [Abstract][Full Text] [Related]
112. Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment. Sunkara A; Raizner A Methodist Debakey Cardiovasc J; 2019; 15(3):179-184. PubMed ID: 31687096 [TBL] [Abstract][Full Text] [Related]
113. Role of Vitamins in Cardiovascular Health: Know Your Facts-Part 2. Manolis AA; Manolis TA; Melita H; Manolis AS Curr Vasc Pharmacol; 2023; 21(6):399-423. PubMed ID: 37694779 [TBL] [Abstract][Full Text] [Related]
114. Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Biesalski HK; Grune T; Tinz J; Zöllner I; Blumberg JB Nutrients; 2010 Sep; 2(9):929-49. PubMed ID: 22254063 [TBL] [Abstract][Full Text] [Related]
115. Vitamin intake and risk of coronary disease: observation versus intervention. Moats C; Rimm EB Curr Atheroscler Rep; 2007 Dec; 9(6):508-14. PubMed ID: 18377792 [TBL] [Abstract][Full Text] [Related]
116. Contributions of observational evidence and clinical trials in cancer prevention. Hennekens CH; Buring JE Cancer; 1994 Nov; 74(9 Suppl):2625-9. PubMed ID: 7954276 [TBL] [Abstract][Full Text] [Related]
117. Antiatherogenic effects of vitamin E: the search for the Holy Grail. Kirmizis D; Chatzidimitriou D Vasc Health Risk Manag; 2009; 5():767-74. PubMed ID: 19774218 [TBL] [Abstract][Full Text] [Related]
118. Oxygen free radicals and antioxidants: a review. Barber DA; Harris SR Am Pharm; 1994 Sep; NS34(9):26-35. PubMed ID: 7977023 [TBL] [Abstract][Full Text] [Related]
119. Mitomycin C-activity effected by vitamins B1, C, E and beta-carotene under irradiation with gamma-rays. Heinrich E; Getoff N Z Naturforsch C J Biosci; 2003; 58(3-4):244-8. PubMed ID: 12710736 [TBL] [Abstract][Full Text] [Related]
120. Epidemiologic studies of antioxidants and cancer in humans. Flagg EW; Coates RJ; Greenberg RS J Am Coll Nutr; 1995 Oct; 14(5):419-27. PubMed ID: 8522720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]